EUVIMEDEUVIMED entdecken
Crossref

Utility of Reticulocyte Hemoglobin Equivalent in Screening for Iron Deficiency in Pregnancy

Lylach Haizler-Cohen iD, Haleema Saeed, Valencia Quiett, Gurpinder Kaur, Eshetu A Tefera, Samrawit Gizaw, Richard Verstraete, Michael Auerbach, Nicholas Hazen

American Journal of Perinatology · 01.05.2025 · 42 (07) · 834-841

DOI: 10.1055/a-2419-9404 ↗

Kurz gefasst

Fachartikel in der Zeitschrift American Journal of Perinatology, erschienen am 01.05.2025. Verfasst von Lylach Haizler-Cohen und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, MedStar Washington Hospital Center, Washington, District of Columbia. Hauptthemen laut MEDLINE: Ferritins, Hemoglobins, Pregnancy Complications, Hematologic, Anemia, Iron-Deficiency. Die Arbeit nennt 24 Literaturangaben. Gefördert von: Medstar Graduate Medical Education.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ferritin, commonly used for diagnosing iron deficiency (ID) in pregnancy, is limited by high cost and false elevations during inflammation. Reticulocyte hemoglobin equivalent (Ret-He), an alternative marker for ID, is unaffected by inflammation and analyzed on the same collection tube as the standard complete blood count (CBC). We aimed to determine the accuracy of Ret-He in detecting ID in pregnancy compared to ferritin in a U.S. cohort. This prospective cohort study enrolled 200 pregnant participants, recruited in any trimester if a CBC was drawn as part of routine prenatal care. For those who agreed to participate, Ret-He and ferritin were collected concurrently with the CBC. ID was defined as ferritin level below 30 ng/mL. Patients were classified into three groups based on hemoglobin and ferritin results to determine the severity of ID: no ID, ID alone, and ID anemia (IDA). Four participants with anemia but normal ferritin were excluded. Receiver operating curve analysis, including the area under the curve (AUC), was performed to assess the accuracy of Ret-He in detecting ID. A one-way ANOVA (analysis of variance) with post-hoc analysis was used to compare differences in Ret-He between the three groups of ID severity. The prevalence of ID in our cohort was 82% (161/196). The AUC for Ret-He was 0.65 (95% confidence interval: 0.55–0.75), indicating suboptimal discrimination between patients with and without ID. Ret-He was significantly different among the three groups (p < 0.001). In post-hoc analysis, Ret-He was significantly lower in the IDA group compared to the ID group (p < 0.001) but there was only a trend of lower Ret-He in the ID group compared to the non-ID group (p = 0.38). Ret-He has low accuracy in diagnosing ID in pregnancy. It may be useful in detecting severe ID resulting in anemia but not a mild iron-deficient state resulting in ID only.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FerritinsHemoglobinsPregnancy Complications, HematologicAnemia, Iron-DeficiencyReticulocytesIron DeficienciesHumansFemalePregnancyProspective StudiesAdultROC CurveBiomarkersYoung AdultArea Under Curve

Substanzen

FerritinsHemoglobinsBiomarkers

Autor:innen und Institutionen

  • Department of Obstetrics and Gynecology, MedStar Washington Hospital Center, Washington, District of Columbia.
  • Bloodless Medicine and Surgery Program, MedStar Georgetown University Hospital, Washington, District of Columbia.
  • Department of Biostatistics, MedStar Health Research Institute, Hyattsville, Maryland.
  • Department of Medicine, Georgetown University School of Medicine, Washington, District of Columbia.
  • Department of Obstetrics and Gynecology, MedStar Georgetown University Hospital, Washington, District of Columbia.

ORCID-Profile: Lylach Haizler-Cohen

Förderung

  • Medstar Graduate Medical Education

Zitieren

APA

Haizler-Cohen, L., Saeed, H., Quiett, V., Kaur, G., Tefera, E. A., Gizaw, S., Verstraete, R., Auerbach, M., & Hazen, N. (2025). Utility of Reticulocyte Hemoglobin Equivalent in Screening for Iron Deficiency in Pregnancy. American Journal of Perinatology, 42(07), 834-841. https://doi.org/10.1055/a-2419-9404

Vancouver

Haizler-Cohen L, Saeed H, Quiett V, Kaur G, Tefera EA, Gizaw S, et al. Utility of Reticulocyte Hemoglobin Equivalent in Screening for Iron Deficiency in Pregnancy. American Journal of Perinatology. 2025;42(07):834-841. doi:10.1055/a-2419-9404

BibTeX
@article{HaizlerCohen2025,
  author = {Haizler-Cohen, Lylach and Saeed, Haleema and Quiett, Valencia and Kaur, Gurpinder and Tefera, Eshetu A and Gizaw, Samrawit and Verstraete, Richard and Auerbach, Michael and Hazen, Nicholas},
  title = {Utility of Reticulocyte Hemoglobin Equivalent in Screening for Iron Deficiency in Pregnancy},
  journal = {American Journal of Perinatology},
  year = {2025},
  volume = {42},
  number = {07},
  pages = {834--841},
  doi = {10.1055/a-2419-9404}
}
Kostenlos starten →